3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
6
Phase 2
6
Phase 1/2
2
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
73
Thoracic
17
Breast
16
Gynecologic
13
Head & Neck
11
Genitourinary
11
Dermatologic
7
Sarcoma
6
CNS
5
Endocrine
2
NET
1
Lymphoid
1
Conditions
Neuroendocrine Tumors
60
Neoplasms
7
Gastro-enteropancreatic neuroendocrine tumor
7
Carcinoid Tumor
6
Breast Neoplasms
6
Pheochromocytoma
5
Colorectal Neoplasms
5
Carcinoma, Renal Cell
5
Adenoma, Islet Cell
5
Urinary Bladder Neoplasms
4
Thyroid Neoplasms
4
Paraganglioma
4
Neoplasm Metastasis
4
Lung Neoplasms
4
Carcinoma, Neuroendocrine
4
Carcinoma, Hepatocellular
4
Brain Neoplasms
4
Small Cell Lung Carcinoma
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Melanoma
3
Carcinoma, Medullary
3
Adrenocortical Carcinoma
3
Uveal Melanoma
2
Uterine Cervical Neoplasms
2
Testicular Neoplasms
2
Sarcoma
2
Neuroectodermal Tumors, Primitive
2
Lymphoma
2
Liver Neoplasms
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Gastrointestinal Neoplasms
×
NET
×
Clear all
NCT03411915
2022-05-10
DUET-1
Xencor, Inc.
Phase 1
Completed
62 enrolled